| Trial Identifier: | D9673R00037 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT06131424 |
| Start Date: | April 2024 |
| Primary Completion Date: | September 2025 |
| Study Completion Date: | September 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Brazil | Sao Paulo, Brazil |
| Dominican Republic | Santo Domingo, Dominican Republic |
| India | Bengaluru, India |
| India | Delhi, India |
| India | Hyderabad, India |
| India | Kochi, India |
| India | Mumbai, India |
| India | Varanasi, India |
| Indonesia | Jakarta, Indonesia |
| Malaysia | Kaula Lumpur, Malaysia |
| Malaysia | Subang Jaya, Malaysia |
| Mexico | Ciudad de Mexico, Mexico |
| Panama | Panama, Panama |
| Philippines | Quezon city, Philippines |
| Singapore | Singapore, Singapore |
| Thailand | Bangkok, Thailand |
| Vietnam | Hanoi, Vietnam |
| Vietnam | Ho Chi Minh, Vietnam |
| Vietnam | Hue, Vietnam |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company